<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 19-year-old female with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> for four years, and a 73-year-old female with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> for twenty years developed sudden-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Examination by light microscopy, immunofluorescence, and electron microscopy (in one case) identified <z:e sem="disease" ids="C0027721" disease_type="Disease or Syndrome" abbrv="">minimal change disease</z:e> (MCD) in both cases </plain></SENT>
<SENT sid="2" pm="."><plain>There was a potential causative drug (meloxicam) for the 73-year-old patient </plain></SENT>
<SENT sid="3" pm="."><plain>Both patients were treated with <z:chebi fb="0" ids="8382">prednisone</z:chebi> and responded with complete remission </plain></SENT>
<SENT sid="4" pm="."><plain>The patient with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> showed complete remission without relapse, and the patient with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> had two relapses; complete remission was sustained after associated treatment with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and <z:chebi fb="0" ids="8382">prednisone</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Both patients had two years of follow-up evaluation after remission </plain></SENT>
<SENT sid="6" pm="."><plain>We discuss the outcomes of both patients and emphasize the role of kidney biopsy in diabetic patients with an atypical proteinuric clinical course, because patients with MCD clearly respond to corticotherapy alone or in conjunction with other <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
</text></document>